Market Exclusive

Analyst Activity – Maxim Group Reiterates Buy on Anavex Life Sciences Corp. (NASDAQ:AVXL)

Analyst Ratings For Anavex Life Sciences Corp. (NASDAQ:AVXL)

Today, Maxim Group reiterated its Buy rating on Anavex Life Sciences Corp. (NASDAQ:AVXL) with a price target of $15.00.

There are 3 buy ratings on the stock.

The current consensus rating on Anavex Life Sciences Corp. (NASDAQ:AVXL) is Buy (Score: 3.00) with a consensus target price of $13.67 per share, a potential 180.63% upside.

Some recent analyst ratings include

Recent Insider Trading Activity For Anavex Life Sciences Corp. (NASDAQ:AVXL)
Anavex Life Sciences Corp. (NASDAQ:AVXL) has insider ownership of 11.60% and institutional ownership of 22.78%.

Recent Trading Activity for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Shares of Anavex Life Sciences Corp. closed the previous trading session at 4.87 down -0.13 -2.60% with 580,945 shares trading hands.

Exit mobile version